Ren X et al. |
Effect of Intravenous Iron Supplementation on Acute Mountain Sickness: A Preliminary Randomized Controlled Study. |
2015 |
Med. Sci. Monit. |
pmid:26175087
|
Agarwal R et al. |
A randomized trial of intravenous and oral iron in chronic kidney disease. |
2015 |
Kidney Int. |
pmid:26083656
|
Connor JR et al. |
Comparative evaluation of nephrotoxicity and management by macrophages of intravenous pharmaceutical iron formulations. |
2015 |
PLoS ONE |
pmid:25973894
|
Bhandari S et al. |
A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients. |
2015 |
Nephrol. Dial. Transplant. |
pmid:25925701
|
Toblli JE et al. |
Cardiovascular outcomes of intravenous iron in perspective of clinical trials and the use of different iron preparations. |
2015 |
Int. J. Cardiol. |
pmid:25838213
|
Almilaji A et al. |
Regulation of the voltage gated K channel Kv1.3 by recombinant human klotho protein. |
2014 |
Kidney Blood Press. Res. |
pmid:25571875
|
Sasaki Y et al. |
Hepcidin production in response to iron is controlled by monocyte-derived humoral factors. |
2014 |
Int. J. Hematol. |
pmid:24293278
|
Raman S et al. |
Evolution-guided optimization of biosynthetic pathways. |
2014 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:25453111
|
Lu QY et al. |
Overestimation of flavonoid aglycones as a result of the ex vivo deconjugation of glucuronides by the tissue β-glucuronidase. |
2014 |
J Pharm Biomed Anal |
pmid:24176739
|
Beguin Y and Jaspers A |
Iron sucrose - characteristics, efficacy and regulatory aspects of an established treatment of iron deficiency and iron-deficiency anemia in a broad range of therapeutic areas. |
2014 |
Expert Opin Pharmacother |
pmid:25186219
|
Price E et al. |
A prospective randomized wait list control trial of intravenous iron sucrose in older adults with unexplained anemia and serum ferritin 20-200 ng/mL. |
2014 |
Blood Cells Mol. Dis. |
pmid:25065855
|
Kuo KL et al. |
Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD. |
2014 |
J. Am. Soc. Nephrol. |
pmid:24722448
|
Macdougall IC et al. |
A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD. |
2014 |
Clin J Am Soc Nephrol |
pmid:24458078
|
Contreras C et al. |
Comparative study of the oral absorption of microencapsulated ferric saccharate and ferrous sulfate in humans. |
2014 |
Eur J Nutr |
pmid:23892521
|
Corwin HL and Napolitano LM |
Anemia in the critically ill: do we need to live with it?*. |
2014 |
Crit. Care Med. |
pmid:25126804
|
Pieracci FM et al. |
A multicenter, randomized clinical trial of IV iron supplementation for anemia of traumatic critical illness*. |
2014 |
Crit. Care Med. |
pmid:24797376
|
Hetzel D et al. |
A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy. |
2014 |
Am. J. Hematol. |
pmid:24639149
|
Perelló MF et al. |
Intravenous ferrous sucrose versus placebo in addition to oral iron therapy for the treatment of severe postpartum anaemia: a randomised controlled trial. |
2014 |
BJOG |
pmid:24423186
|
Toyokuni S |
Iron overload as a major targetable pathogenesis of asbestos-induced mesothelial carcinogenesis. |
2014 |
Redox Rep. |
pmid:24257681
|
Onken JE et al. |
Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial. |
2014 |
Nephrol. Dial. Transplant. |
pmid:23963731
|